Tag
Tag: Genfit
The First Approved NASH Therapy?
Genfit’s NASH Drug to Be Developed in China in Deal Worth up to €200M
Genfit Gets Ready to Launch Drug for Untreated Liver Disease Raising €120M
NASH Leader goes Pediatric with Clinical Trial Launch in US
Bored Between the Holidays? Watch these Biotech Videos!
Genfit Gets €180M Cash Injection to Bring its Pipeline to Market
These Three Fields Are Proving Biotech is The Innovation Powerhouse in Healthcare
The Advantage for the First Mover in NASH is Limited, says Genfit
Genfit Delays Phase III Enrollment in the Race for the First NASH Therapy
Two Big Pharma Players Team up to Take Over the NASH Space
